Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
23.05. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
16.05. | Vivos Therapeutics GAAP EPS of -$0.45 misses by $0.10, revenue of $3.02M misses by $1.18M | 2 | Seeking Alpha | ||
16.05. | Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 | 1 | Seeking Alpha | ||
15.05. | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
15.05. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update | 117 | GlobeNewswire (Europe) | Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its... ► Artikel lesen | |
17.04. | Vivos Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
16.04. | Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada | 1 | Seeking Alpha | ||
VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
16.04. | Vivos Therapeutics, Inc: Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada | 92 | GlobeNewswire (Europe) | By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to... ► Artikel lesen | |
31.03. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
31.03. | Vivos Therapeutics GAAP EPS of -$2.22 misses by $0.20, revenue of $15.03M misses by $0.17M | 5 | Seeking Alpha | ||
31.03. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update | 75 | GlobeNewswire (Europe) | Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo.... ► Artikel lesen | |
31.03. | Vivos Therapeutics, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
28.03. | Earnings Outlook For Vivos Therapeutics | 2 | Benzinga.com | ||
18.02. | Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET. | 1 | GlobeNewswire (USA) | ||
14.02. | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
11.02. | Vivos Therapeutics announces up to $50M mixed shelf offering | 1 | Seeking Alpha | ||
29.01. | Vivos Therapeutics, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
22.01. | Vivos Therapeutics announces sale of up to 854,332 shares by selling stockholders | 1 | Seeking Alpha | ||
22.01. | Vivos Therapeutics, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
23.12.24 | Vivos Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 64,65 | -4,08 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler veranstaltet drittes Boston Radionuclide Theranostics Forum | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): Sonstiges
Eckert & Ziegler veranstaltet drittes Boston Radionuclide Theranostics Forum
30.05.2025 / 10:00 CET/CEST
Für... ► Artikel lesen | |
INTUITIVE SURGICAL | 491,25 | +0,66 % | Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential | ||
SERNOVA BIOTHERAPEUTICS | 0,109 | +1,87 % | Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy | Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group.... ► Artikel lesen | |
SYNLAB | 12,650 | -0,47 % | Schock-News für Synlab Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
NUGEN MEDICAL DEVICES | 0,040 | +0,50 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
PLUS THERAPEUTICS | 0,316 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights | Company continues to progress both REYOBIQ radiotherapeutic clinical trials and CNSide® CSF assay platform launch readiness HOUSTON, May 30, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:... ► Artikel lesen | |
CARDINAL HEALTH | 134,65 | -0,04 % | Cardinal Health Launches 3-in-1 Continuous Vital Signs Monitoring System | WASHINGTON (dpa-AFX) - Cardinal Health Inc (CAH) Wednesday said it has launched Kendall DL Multi System, a new medical device to help continuously monitor three vital signs including cardiac... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,783 | +4,54 % | Ascendiant Capital raises Atossa Genetics stock price target to $7.50 | ||
UNIDOC HEALTH | 0,160 | -2,91 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports First Quarter 2025 Financial Results and Provides Business Update | SAN DIEGO, May 15, 2025 /PRNewswire/ -- Women's health innovator Evofem Biosciences, Inc. (OTCPK: EVFM), today announced financial results for the first quarter... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,260 | -0,58 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
GERRESHEIMER | 48,160 | -1,99 % | Märkte am Morgen: Gerresheimer, BioNTech, Delivery Hero, Boeing, US-Stahlwerte, Rheinmetall | Der DAX befindet sich in dieser Woche auf Richtungssuche. Gestern gab er leicht ab, heute deuten sich zum Start leichte Gewinne an. Dabei profitiert der deutsche Leitindex von positiven Vorgaben aus... ► Artikel lesen | |
FRESENIUS | 44,170 | -0,16 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Fresenius von 48 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Zwar habe er seine Gewinnerwartungen infolge... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 65,11 | 0,00 % | Procept Biorobotics auf Jefferies-Konferenz: Strategische Innovationen in der BPH-Behandlung | ||
FRESENIUS MEDICAL CARE | 50,18 | -0,67 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC von 37 auf 40 Euro angehoben, aber die Einstufung auf "Underperform" belassen. Zwar habe er seine Gewinnerwartungen infolge... ► Artikel lesen |